Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Comparison of population pharmacokinetics based on steady-state assumption versus electronically monitored adherence to lopinavir
Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP
Promising results from a few clinical pilote studies reveal that salinomycin is able to effectively eliminate CSCs and to induce partial clinical regression of heavily pretreated and therapy-resistant cancers
Woodruff in 1940
WIN-55212-2 mesylate evokes CGRP release from TG neurons in vitro (EC50=26 μM) in a concentration- and calcium-dependent manner
BAY-1251152 racemate - CAS# 1610358-53-6 0158 Comparison of population pharmacokinetics basedBAY 1251152 racemate, CAS No. 1610358 53 6, also known as () BAY 1251152, is a racemic mixture of BAY 1251152. BAY 1251152 is a potent and highly selective PTEF CDK9 inhibitor. BAY 1251152 racemate, CAS No. 1610358 53 6, binds to and blocks the phosphorylation and kinase activity of CDK9, thereby preventing PTEFb mediated activation of RNA Pol II and leading to the inhibition of gene transcription of various anti apoptotic proteins. This may cause
US$ 3100.00
US$ 3250.00
US$ 3150.00
US$ 3250.00
US$ 3100.00
US$ 3100.00